Oncology Nursing News®

Web Exclusives

$FDA Grants Priority Review to Belantamab Mafodotin for Relapsed/Refractory Myeloma$

FDA Grants Priority Review to Belantamab Mafodotin for Relapsed/Refractory Myeloma

BY KRISTIE L. KAHL

FDA Grants Fast Track Designation to Oncoprex Combination for NSCLC

BY KRISTIE L. KAHL

Detecting and Managing irAEs in Melanoma Is Crucial

Detecting and Managing irAEs in Melanoma Is Crucial

BY BRITTANY COTE

Radiation's Role Shifts in Breast Cancer

Radiation's Role Shifts in Breast Cancer

BY JESSICA HERGERT

Deciding on Treatment for Metastatic Melanoma

Deciding on Treatment for Metastatic Melanoma

BY KRISTI ROSA

FDA Warns Against Potentially Contaminated Surgical Gowns

FDA Warns Against Potentially Contaminated Surgical Gowns

BY BRIELLE BENYON

FDA Grants Priority Review to Rucaparib for BRCA1/2-Positive mCRPC

FDA Grants Priority Review to Rucaparib for BRCA1/2-Positive mCRPC

BY KRISTIE L. KAHL

FDA Grants Priority Review to Frontline Nivolumab-Ipilimumab Combo for NSCLC

FDA Grants Priority Review to Frontline Nivolumab-Ipilimumab Combo for NSCLC

BY KRISTIE L. KAHL

Managing irAEs is a

Managing irAEs is a "Dynamic Discussion"

BY BRIELLE BENYON AND GINA COLUMBUS

Luspatercept Reduces Anemia in Patients With MDS

Luspatercept Reduces Anemia in Patients With MDS

BY BRITTANY COTE

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.